GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Getinge
Who buys from Getinge today?
Getinge’s shift to software-enabled surgical and ICU solutions reshaped its buyer base: hospitals, ambulatory surgical centers, and bioprocessing labs seeking efficiency, compliance, and uptime amid staffing shortages.
Customer demographics center on large hospital systems, specialty clinics, and life-science firms in North America, Europe, and APAC; procurement prioritizes reliability, regulatory compliance, and digital integration. See product context: Getinge Porter's Five Forces Analysis
Who Are Getinge’s Main Customers?
Getinge’s primary customer segments are B2B and split into Acute Care Therapies, Life Science, and Surgical Workflows, serving hospitals, biopharma firms and research labs across public and private health systems.
Acute Care Therapies
Accounts for 54% of 2025 net sales; targets ICUs and cardiovascular clinics, selling ventilators, ECMO and perfusion systems to intensivists, perfusionists and cardiac surgeons.
Life Science
Represents about 18% of revenue with the fastest growth at 8.5% YoY; customers are pharmaceutical manufacturers and research labs needing sterile transfer systems and bioreactors.
Surgical Workflows
Contributes roughly 28% of sales; buyers include hospital CEOs and procurement officers, end-users are surgeons and surgical nurses requiring integrated OR equipment and ergonomic solutions.
Geographic & market shift
Historically Europe-focused on public hospitals; by 2025 a clear shift toward private healthcare groups and biopharma manufacturers in North America and Asia driven by biopharma expansion and OR upgrades in emerging markets.
Channeling sales toward large hospital systems and biopharma OEMs aligns with Getinge’s product mix and customer needs while influencing the company profile and segmentation strategies; see related analysis in Revenue Streams & Business Model of Getinge
Customer Decision Makers & End-Users
Decision-making typically sits with hospital administrators and procurement; clinical end-users validate purchases based on safety and ergonomics.
- Primary buyers: hospital CEOs, procurement officers
- Clinical influencers: intensivists, cardiac surgeons, surgical nurses
- Industrial clients: biopharma C-suite, process engineers
- Geographic focus: increasing share in North America and Asia
What Do Getinge’s Customers Want?
Getinge customers prioritize clinical efficacy, patient safety and total cost of ownership; in 2025 purchasing also hinges on product digital maturity and EHR integration to reduce manual entry and errors.
Clinical efficacy and patient safety
Surgeons and ICU staff prefer equipment known for reliability in life-critical settings; brand trust drives procurement for high-stakes care.
Digital maturity and interoperability
Hospitals demand devices that integrate with EHRs and hospital systems to lower manual data entry and minimize human error.
Operational efficiency
Maximizing OR throughput and reducing turnover time are critical; modular OR solutions and automated sterile reprocessing address these needs.
Infection control
Reducing hospital-acquired infections is a top priority; sterilizer performance and validated reprocessing workflows are key purchase criteria.
Flexibility for life sciences
Bioprocessing customers favor scalable single-use technologies to cut cleaning validation and accelerate time-to-market.
After-sales support and service
Customers show strong preference for comprehensive service contracts and 24/7 technical assistance; Getinge Care expansion targets this loyalty driver.
Customer Needs and Preferences continue below
Behavioral and procurement trends
Procurement teams assess total cost of ownership, uptime guarantees and digital integration; psychological drivers include risk aversion in critical care.
- Clinical outcomes and safety as primary buying criteria
- Integration with EHR/hospital systems increasingly decisive in 2025
- Demand for automation to boost OR throughput and reduce HAIs
- Preference for strong service contracts and 24/7 support
Evidence and metrics
Supporting data
Industry feedback and sales data indicate a >50% increase in procurement weight assigned to interoperability and digital features by 2025; reported OR turnover reductions of 20–30% with modular solutions; infection-control investments grew by 12% in 2024–25.
- Getinge targets hospitals, surgical centers, ICUs and life science firms in its market segmentation
- Customer base analysis highlights preference for bundled service contracts and expansion of Getinge Care
- Geographic focus includes Europe and North America where digital integration requirements are highest
- See corporate values and strategic direction in Mission, Vision & Core Values of Getinge
Where does Getinge operate?
Getinge's geographical market presence spans over 125 countries, balancing mature and growth regions with tailored regional strategies and localized operations to serve diverse healthcare needs.
Regional Revenue Split
As of late 2025, the Americas account for 41% of net sales, EMEA 36%, and APAC 23%, reflecting strong demand in cardiovascular and life science solutions in the US and stable sterile reprocessing demand in Europe.
Key Country Markets
Top markets include the United States, Germany, France and the Nordic countries in EMEA, while China and India are prioritized in APAC for expansion of basic surgical and ICU equipment.
Localization Strategy
Getinge uses regional manufacturing hubs, localized marketing, and training programs; US efforts emphasize high-end innovation and digital integration, ASEAN focus stresses durability and maintenance support.
Logistics and Portfolio Moves
Recent investments expanded logistics centers in Singapore to serve ASEAN; the company has tactically exited low-margin commodity segments in parts of Eastern Europe to prioritize high-value clinical solutions.
Market Segmentation Focus
Getinge segments markets by healthcare system type and purchasing power, targeting hospitals, surgical centers and life science labs with differentiated offerings and service levels.
Growth Drivers
Demand for advanced cardiovascular devices in North America and expanding basic surgical/ICU capacity in China and India are primary growth drivers for 2025 and beyond.
Competitive Positioning
In EMEA, Getinge holds strong share in sterile reprocessing and surgical infrastructure, leveraging long-standing relationships in Germany, France and the Nordics.
Operational Priorities
Priority actions include strengthening regional supply chains, investing in service networks, and aligning products to local clinical and budgetary requirements.
Customer Demographics
Primary customers are hospitals, surgical centers and life science facilities; the ideal customer profile skews toward larger, well-funded institutions in North America and specialized public/private hospitals in EMEA and APAC.
Further Reading
For a deeper look at Getinge target market segmentation and customer demographics, see Target Market of Getinge.
How Does Getinge Win & Keep Customers?
Customer acquisition relies on a global direct sales force, large public/private tenders, digital marketing and VR demos; retention focuses on long-term service agreements, remote monitoring and clinical training to convert sales into ongoing partnerships.
Direct Sales & Tenders
Getinge’s direct sales teams and tender participation secure large institutional contracts across hospitals and health systems, targeting procurement cycles and capital budgets.
Digital & VR Demonstrations
By 2025 Getinge expanded VR demonstrations and digital marketing to present integrated OR and critical care solutions to hospital boards worldwide, reducing reliance on physical showrooms.
Experience Centers
Experience Centers in locations such as Frankfurt and New Jersey let buyers interact with full-scale clinical environments, accelerating procurement decisions and cross-sell opportunities.
Data-driven CRM
CRM analytics identify equipment replacement cycles and service needs, enabling timely upgrade offers and protecting market share from competitors.
Connected Installed Base
Over 60 percent of ventilators and sterilizers were connected to remote monitoring by 2025, enabling predictive maintenance and reduced downtime.
Getinge Online Ecosystem
The Getinge Online platform shifts revenue from one-off sales to recurring service contracts, increasing customer lifetime value and service revenue share.
Getinge Academy
Ongoing clinical training and certification for hospital staff builds product familiarity and brand loyalty, supporting retention among practitioners and procurement teams.
Low Churn Among Top Clients
Service and connectivity initiatives helped maintain a churn rate below 5 percent for top-tier institutional customers as of 2025.
Target Market Alignment
Strategies are tailored to Getinge’s target market of hospitals, surgical centers and life science labs, aligning sales, service and training to customer demographics and purchasing behavior.
Resource for Context
For historical and company context see Brief History of Getinge.
- What is Brief History of Getinge Company?
- What is Competitive Landscape of Getinge Company?
- What is Growth Strategy and Future Prospects of Getinge Company?
- How Does Getinge Company Work?
- What is Sales and Marketing Strategy of Getinge Company?
- What are Mission Vision & Core Values of Getinge Company?
- Who Owns Getinge Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.